Infection Outcomes in Solid Organ Transplant Recipients Receiving Trimethoprim-Sulfamethoxazole as Opposed to Atovaquone for Prophylaxis.

被引：0
|
作者：
Drelick, A. [1 ]
Mowrey, W. [2 ]
Minamoto, G. [3 ,4 ]
机构：
[1] Weill Cornell Med Ctr, Div Infect Dis, Med, New York, NY USA
[2] Albert Einstein Coll Med, Epidemiol & Populat Hlth, Bronx, NY 10467 USA
[3] Montefiore Med Ctr, Div Infect Dis, Med, 111 E 210th St, Bronx, NY 10467 USA
[4] Albert Einstein Coll Med, Bronx, NY 10467 USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2018年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
C347
引用
收藏
页码：887 / 887
页数：1
相关论文
共 50 条
  • [21] INTERSTITIAL NEPHRITIS CAUSED BY TRIMETHOPRIM-SULFAMETHOXAZOLE IN RENAL-TRANSPLANT RECIPIENTS
    SMITH, EJ
    LIGHT, JA
    FILO, RS
    YUM, MN
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1980, 244 (04): : 360 - 361
  • [22] Lower Rates of Staphylococcus aureus Bloodstream Infection in Patients on Hemodialysis Receiving Trimethoprim-Sulfamethoxazole Melioidosis Prophylaxis
    Bryce, Aliya
    Davison, Sara
    Currie, Bart J.
    Birrell, Johanna M.
    Baird, Robert W.
    Abeyaratne, Asanga
    Majoni, Sandawana William
    Brewster-O'Brien, Teana
    Tong, Steven Y. C.
    OPEN FORUM INFECTIOUS DISEASES, 2024, 11 (08):
  • [23] Higher risk of urinary tract infections in renal transplant recipients receiving pentamidine versus trimethoprim-sulfamethoxazole (TMP-SMX) forPneumocystispneumonia prophylaxis
    Fu, Whitney
    Barahona, Maria
    Harkness, Taylor
    Cohen, Elizabeth
    Reardon, David
    Yoo, Peter S.
    CLINICAL TRANSPLANTATION, 2020, 34 (11)
  • [24] Effective alternates to trimethoprim-sulfamethoxazole as antimicrobial prophylaxis in stem cell recipients: Are there any?
    Ramesh, Mayur
    Chandrasekar, Pranatharthi H.
    PEDIATRIC TRANSPLANTATION, 2008, 12 (08) : 823 - 826
  • [25] Reinstituting trimethoprim-sulfamethoxazole in patients receiving atovapuone for Pneumocystis carinii pneumonia prophylaxis
    James, CW
    McNelis, KC
    Szabo, S
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2003, 60 (15) : 1572 - 1574
  • [26] Prophylaxis of hepatitis B infection in solid organ transplant recipients
    John, Savio
    Andersson, Karin L.
    Kotton, Camille N.
    Hertl, Martin
    Markmann, James F.
    Cosimi, A. Benedict
    Chung, Raymond T.
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2013, 6 (04) : 309 - 319
  • [27] TRIMETHOPRIM-SULFAMETHOXAZOLE-RESISTANT PNEUMOCOCCAL DISEASE IN A PEDIATRIC ACQUIRED-IMMUNODEFICIENCY-SYNDROME PATIENT RECEIVING TRIMETHOPRIM-SULFAMETHOXAZOLE PROPHYLAXIS
    SLOBOD, KS
    LEGGIADRO, RJ
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1994, 13 (05) : 423 - 424
  • [28] Discontinuation of Trimethoprim/sulfamethoxazole Prophylaxis Due to Hyperkalemia in Kidney Transplant Recipients
    Pett, D.
    Malat, G.
    Domenico, C.
    Samudralwar, R.
    Forte, A.
    Sawinski, D.
    Hu, J.
    Steiner, B.
    Rashid, J.
    Trofe-Clark, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 : 634 - 634
  • [29] Comparison of atovaquone and azithromycin with trimethoprim-sulfamethoxazole for the prevention of serious bacterial infections in children with HIV infection
    Hughes, WT
    Dankner, WM
    Yogev, R
    Huang, S
    Paul, ME
    Flores, MA
    Kline, MW
    Wei, LJ
    CLINICAL INFECTIOUS DISEASES, 2005, 40 (01) : 136 - 145
  • [30] PREVENTION OF PNEUMOCYSTIS-CARINII PNEUMONIA IN CARDIAC TRANSPLANT RECIPIENTS BY TRIMETHOPRIM-SULFAMETHOXAZOLE
    OLSEN, SL
    RENLUND, DG
    OCONNELL, JB
    TAYLOR, DO
    LASSETTER, JE
    EASTBURN, TE
    HAMMOND, EH
    BRISTOW, MR
    TRANSPLANTATION, 1993, 56 (02) : 359 - 362
12345